Summary:
Mood and Cognition Mobile App – Virtual Clinical Study:
Click Therapeutics is conducting a remote clinical research study to evaluate an investigational mobile app designed to improve mood and cognition in people with multiple sclerosis (MS), mild cognitive impairment, and lung & breast cancer.
The purpose of the study is to understand how the investigational mobile app improves mood symptoms (such as feeling depressed or sad) and cognition (such as being able to pay attention) in different medical conditions with that may affect mood and cognition. No medication will be tested in this virtual clinical study.
In this study, you will be randomly assigned (like the flip of coin) to receive the investigational mobile app or be in a control group. If you are in the control group, you will continue to use your usual medical care and do the study assessments. If you are in the group who receives the investigational mobile app, you will be asked to use the app every day for 3 weeks and do assessments. Total study participation is brief, and will only last up to six weeks.
For taking part in this research, you may be paid up to $141. You will be paid for completing the following study activities before their due date:
- Baseline Survey ($20)
- Week 3 Survey ($25)
- Week 4 Survey ($15)
- If you are assigned to the Study App group: $1 per day that you complete activities in the app, plus a bonus of $20 every week that you complete at least 6 of 7 days (up to $81 total)
- If you are assigned to the control group: bonus of $27 every week that you complete all required study activities (up to $81 total)